Lake Street analyst Ben Klieve upgraded Limoneira (LMNR) to Buy from Hold with an unchanged price target of $23. Q2 results came in “modestly below” the firm’s estimates behind an especially weak lemon market, but the highlight was a major agreement to merge a portion of Limoneira’s operations into Sunkist, which will “meaningfully” reduce Limoneira’s fixed costs and operating expenses while improving the revenue mix to higher margin businesses, the analyst tells investors. Shares being indicated down pre-market is due to “the market navel gazing at Q2’25 results and not the significantly improved outlook,” the analyst contends.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LMNR:
